M6030 Master of Biotechnology

The course is structured in two parts: Part A: Core Biotechnology studies and Part B: Application studies. All students complete Part A. Depending upon prior qualifications, you may receive credit for Part B.

Note: If you are eligible for credit for prior studies you may elect not to receive the credit.

Part A. Core biotechnology studies

These studies present theoretical knowledge in key areas of biotechnology and its applications. You will gain a critical understanding of the designs and methods used in undertaking medical research, and the opportunities and challenges involved in the commercialisation of biotechnology.

Part B. Application studies

In these studies, you will focus on the application of advanced biotechnology practice. You will consolidate your skills, and knowledge and demonstrate your mastery through either a research project and/ or an industry placement program.

In order to be eligible for the industry placement program or the research project, you will be required to achieve at least 70 percent in the core biotechnology component. If you do not meet this requirement, then you must undertake 48 points from the elective list.

Master's entry points

• If you are admitted at entry level 1 you complete 96 points, comprising Parts A and B.
• If you are admitted at entry level 2 you complete 48 points, comprising Part A

Note: If you are eligible for credit for prior studies you may elect not to receive the credit and complete the higher credit point option. If you are admitted at entry level 2 you will not complete the industry placement program or research project.

Course progression map

The course progression map provides guidance on unit enrolment for each semester of study.

The course comprises 96 points structured into two parts: Part A. Core Biotechnology (48 points) and Part B: Application Studies (48 points).

• If you are admitted at entry level 1 you complete 96 points, comprising Parts A and B.
• If you are admitted at entry level 2 you complete 48 points, comprising Part A.

Note: If you are eligible for credit for prior studies you may elect not to receive the credit and complete the higher credit point option.

Units are 6 credit points unless otherwise stated.

Part A. Core biotechnology studies (48 points)

You must complete:

• BRM5011 Foundations for medical biotechnology and its applications
• BRM5012 Techniques in medical biotechnology: genomics, proteomics and bioinformatics
• BRM5013 Techniques in medical biotechnology: Imaging, iPS cells, cell and gene therapies
• GEN5010 Advanced genetics and biotechnology
• BRM5015 Biotechnology research studies
• BEX5411 Creativity and entrepreneurship
• BMS5007 Biotechnology: Commercialising biomedical science
• BRM5014 Therapeutic approaches and biotechnology

Part B. Application studies (48 points)

In order to be eligible for the research project or industry placement, you need to have an average of at least 70% in your core biotechnology studies (Part A).    If you do not meet this requirement, then you can undertake 48 points from the elective list or you may exit and graduate with a Graduate Diploma of Biotechnology.

You must complete either a. or b. below:

a. Research pathway

• BRM5021 Biotechnology research project (48 points) 

b. Coursework pathway

• BRM5022 Biotechnology work-integrated learning (24 points) *
• four units from the elective list below

* You must have a successful application with a company to undertake this unit,  Training on how to write a CV and to prepare for an interview is available and you will be provided the opportunity to apply to up to five organisations.

Elective list

• MTE5885 Biomaterials and Biomechanics
• MPH5269 Foundations of health policy 
• FOR5007 Elements of forensic toxicology
• BFC5925 Financial management theory 
• MPH5264 Economic management in healthcare
• MEC5889 Medical device technologies
• EPM5023 Foundations of international health
• MPH5272 Principles of health systems 
• BMS5003 Infectious diseases and population health
• BMS5012 Cancer biology and therapeutics